Similar articles

• [Medical treatment of gallstones (author's transl)].

  Gérolami A, Montet JC, Marteau C, Reynier MO, Crotte C. Gérolami A, et al. Gastroenterol Clin Biol. 1980;4(8-9):588-99. Gastroenterol Clin Biol. 1980. PMID: 7000610 Review. French. No abstract available.
• Gallstone dissolution and the cholesterol--bile acid--lipoprotein axis. Propitious effects of ursodeoxycholic acid.

  Fromm H. Fromm H. Gastroenterology. 1984 Jul;87(1):229-33. Gastroenterology. 1984. PMID: 6724267 No abstract available.
• Effect of litholytic bile acids on cholesterol absorption in gallstone patients.

  LaRusso NF, Thistle JL. LaRusso NF, et al. Gastroenterology. 1983 Feb;84(2):265-71. Gastroenterology. 1983. PMID: 6848406 Clinical Trial.
• Ursodiol: a cholesterol gallstone solubilizing agent.

  Rosenbaum CL, Cluxton RJ Jr. Rosenbaum CL, et al. Drug Intell Clin Pharm. 1988 Dec;22(12):941-5. doi: 10.1177/106002808802201202. Drug Intell Clin Pharm. 1988. PMID: 3072172 Review.
• Comparative efficacy and side effects of ursodeoxycholic and chenodeoxycholic acids in dissolving gallstones. A double-blind controlled study.

  Fromm H, Roat JW, Gonzalez V, Sarva RP, Farivar S. Fromm H, et al. Gastroenterology. 1983 Dec;85(6):1257-64. Gastroenterology. 1983. PMID: 6354826 Clinical Trial.